New England Research & Management Inc. Has $481,000 Stake in Roche Holding AG (OTCMKTS:RHHBY)

New England Research & Management Inc. reduced its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 7.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,875 shares of the company’s stock after selling 1,100 shares during the quarter. New England Research & Management Inc.’s holdings in Roche were worth $481,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Wetzel Investment Advisors Inc. purchased a new position in Roche during the fourth quarter valued at approximately $53,000. HighPoint Advisor Group LLC purchased a new position in shares of Roche during the 4th quarter valued at $373,000. Associated Banc Corp increased its stake in shares of Roche by 13.8% in the fourth quarter. Associated Banc Corp now owns 48,484 shares of the company’s stock worth $1,761,000 after acquiring an additional 5,890 shares during the last quarter. Hikari Power Ltd raised its holdings in shares of Roche by 0.8% during the fourth quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock worth $8,616,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Bard Financial Services Inc. boosted its position in Roche by 36.6% during the fourth quarter. Bard Financial Services Inc. now owns 19,800 shares of the company’s stock valued at $717,000 after purchasing an additional 5,300 shares during the last quarter.

Wall Street Analyst Weigh In

Several brokerages have recently commented on RHHBY. The Goldman Sachs Group assumed coverage on shares of Roche in a research note on Thursday, May 30th. They set a “sell” rating on the stock. Deutsche Bank Aktiengesellschaft upgraded Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $40.00.

Roche Price Performance

RHHBY stock traded down $0.08 during midday trading on Tuesday, hitting $39.26. The stock had a trading volume of 1,105,697 shares, compared to its average volume of 2,445,272. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $41.15. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75. The stock has a 50-day simple moving average of $35.72 and a 200 day simple moving average of $33.41.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.